Alter-Ego Robot Launched for ALS Patient Support in Milan
The pilot clinical trial of Alter-Ego, a humanoid robot, has commenced at Irccs Maugeri in Milan, aimed at assisting ALS patients. This initiative evaluates the integration of assistive humanoid robotics in healthcare settings, potentially improving patient care and easing staff workloads.
Theia Market Signal Identification - AI Assisted
The pilot trial of Alter-Ego, a humanoid robot developed by the Istituto Italiano di Tecnologia and the University of Pisa, has begun at Irccs Maugeri in Milan. The project, funded by the Pnrr's complementary plan, aims to assess the feasibility of integrating assistive robotics in care pathways for neurodegenerative diseases, especially ALS.
Alter-Ego, standing at 120 cm and equipped with two robotic arms, operates both autonomously and semi-autonomously to conduct tasks such as patient reception and basic clinical assessments. This initiative emphasizes a multidisciplinary approach, involving clinicians, engineers, and patients to ensure practical applications. The deployment of humanoid robots like Alter-Ego could signify a shift towards more innovative and sustainable healthcare solutions.
Comments